临床药理学创新的历史和演变
Lawrence J Lesko1, Piet H van der Graaf2,3,4
1Center for Pharmacometrics & Systems Pharmacology, College of Pharmacy, University of Florida, Lake Nona, Florida, USA.
Clinical pharmacology and therapeutics
|September 24, 2025
概括
临床药理学的创新,由定量建模和模拟驱动,已经推进了药物开发. 这种发展,跨越了几十年,增强治疗效益风险评估和监管决策更安全的药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 监管科学 监管科学
背景情况:
- 80多年的科学发现是现代临床药理学的基础.
- 从20世纪70年代到80年代的快速进步加速了药物开发和监管过程.
- 转向定量建模和模拟的转变是由改进的数据收集和翻译研究推动的.
研究的目的:
- 审查临床药理学创新的历史演变.
- 检查制药行业与监管机构之间的相互作用.
- 将创新归类为已建立,正在进行或新兴的创新及其未来影响.
主要方法:
- 科学文献和行业监管相互作用的历史审查.
- 分析药物开发和监管科学中的关键创新.
- 根据其当前状态和预计的影响,对创新进行分类.
主要成果:
- 创新导致了精确的剂型评估和优化剂量选择.
- 现在可以更深入地了解药物相互作用和特定人群的剂量调整.
- 该审查对创新进行了分类,说明了它们对将新疗法推向市场的影响.
结论:
- 临床药理学的演变,得到行业监管机构合作的支持,对于开发安全有效的疗法至关重要.
- 定量建模和模拟是当前和未来制药创新的关键驱动力.
- 了解历史趋势为塑造药物开发和监管科学的未来提供了洞察力.
相关概念视频
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


